glp 1 and aromatase inhibitors Glucagon-like Peptide Receptor Agonists in Cardio-Oncology: Pathophysiology of Cardiometabolic Outcomes in Cancer Patients Is GLP-1 Safe for Breast
Description
Explore why weight regain happens after stopping Ozempic, Wegovy, or Mounjaro
Adverse events are mostly gastrointestinal
The primary analysis was an intention-to-treat analysis
Small increases in training load (~30 mins above your usual baseline) show minimal impact on recovery metrics
Some products are meant to complement weight-loss drugs
Discover how protein helps preserve muscle and keep you full.
